“ I strongly believe phage could become an effective antibacterial tool” - Carl Merril, Chief of the Laboratory of Biochemical Genetics, National Institute of Mental Health, NIH.
“ It might be another string on the bow, such that when (conventional antibiotics) fail, here’s something that has a chance of working. But it’s not going to be a panacea” - Joshua Lederberg, Sackler Foundation Scholar at The Rockefeller University
Reassessment of Medicinal Phage Spurs Companies to Study Therapeutic Uses American Society for Microbiology News 64:620-623, 1998
Vancomycin resistant Enterococcus facium and Streptococcus pneumoniae
Phage Therapeutics (Bothell, WA)
Staphylococcus aureus and Staphylococcus epidermidis
Intralytix, Inc. (Baltimore, MD)
Salmonella in meat and poultry
Biopharm Ltd. (Tblisi, Georgia)
Infections associated with burns
University of Idaho
Escherichia coli O157:H7 in cattle
Reassessment of Medicinal Phage Spurs Companies to Study Therapeutic Uses. American Society for Microbiology News 64:620-623, 1998. Phages eyed as agents to protect against harmful E. coli. American Society for Microbiology News 65:666-667, 1999.